Literature DB >> 17879265

Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression.

P O Fernagut1, C B Hutson, S M Fleming, N A Tetreaut, J Salcedo, E Masliah, M F Chesselet.   

Abstract

Genetic variability in the alpha-synuclein gene and long-term exposure to the pesticide paraquat constitute possible risk factors for sporadic Parkinson's disease. The goal of the present study was to further characterize the effects of paraquat in mice as a model of Parkinson's disease and to determine whether it acted synergistically with alpha-synuclein over-expression to cause nigrostriatal cell death or dysfunction. Paraquat (10 mg/kg i.p.) was administered once a week for 3 weeks to mice over-expressing human alpha-synuclein under the Thy1 promoter and their wild-type littermates. The effect of paraquat on catecholaminergic neurons was reminiscent of that of Parkinson's disease, with preferential loss of dopaminergic neurons in the ventral tier of the substantia nigra pars compacta and loss of tyrosine hydroxylase staining in the locus coeruleus. alpha-Synuclein over-expression did not increase paraquat-induced cell loss, and paraquat did not worsen the behavioral deficits observed in the transgenic mice. However, paraquat markedly increased proteinase-K-resistant alpha-synuclein aggregates in substantia nigra of the transgenic mice. The data further validate the use of paraquat to model Parkinson's disease in mice and show that although paraquat and alpha-synuclein over-expression act synergistically to increase protein aggregation in vivo, this interaction does not result in short-term neuroprotection or increased vulnerability of nigrostriatal neurons. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879265      PMCID: PMC3097512          DOI: 10.1002/syn.20456

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  52 in total

Review 1.  The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

Authors:  M G Spillantini; M Goedert
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Axonal sprouting following lesions of the rat substantia nigra.

Authors:  D I Finkelstein; D Stanic; C L Parish; D Tomas; K Dickson; M K Horne
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease.

Authors:  V N Uversky; J Li; A L Fink
Journal:  FEBS Lett       Date:  2001-07-06       Impact factor: 4.124

4.  Neuropathology in mice expressing human alpha-synuclein.

Authors:  H van der Putten; K H Wiederhold; A Probst; S Barbieri; C Mistl; S Danner; S Kauffmann; K Hofele; W P Spooren; M A Ruegg; S Lin; P Caroni; B Sommer; M Tolnay; G Bilbe
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

5.  Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration.

Authors:  Maya G Purisai; Alison L McCormack; Suzanne Cumine; Jie Li; Martha Z Isla; Donato A Di Monte
Journal:  Neurobiol Dis       Date:  2006-12-12       Impact factor: 5.996

Review 6.  Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.

Authors:  Virginia M-Y Lee; John Q Trojanowski
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

7.  Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.

Authors:  Erin H Norris; Kunihiro Uryu; Susan Leight; Benoit I Giasson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

8.  Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.

Authors:  S M Fleming; J Salcedo; C B Hutson; E Rockenstein; E Masliah; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2006-08-23       Impact factor: 3.590

9.  Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.

Authors:  A L McCormack; J G Atienza; J W Langston; D A Di Monte
Journal:  Neuroscience       Date:  2006-05-04       Impact factor: 3.590

Review 10.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.

Authors:  Heiko Braak; Jürgen R Bohl; Christian M Müller; Udo Rüb; Rob A I de Vos; Kelly Del Tredici
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

View more
  82 in total

1.  A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Authors:  Sheila M Fleming; Caitlin K Mulligan; Franziska Richter; Farzad Mortazavi; Vincent Lemesre; Carmen Frias; Chunni Zhu; Alistair Stewart; Illana Gozes; Bruce Morimoto; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2010-12-27       Impact factor: 4.314

Review 2.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

3.  Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein.

Authors:  Sudhakar R Subramaniam; Iddo Magen; Nicholas Bove; Chunni Zhu; Vincent Lemesre; Garima Dutta; Chris Jean Elias; Henry A Lester; Marie-Francoise Chesselet
Journal:  Neurobiol Dis       Date:  2018-06-01       Impact factor: 5.996

4.  Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.

Authors:  TaeHee Kim; Suresh L Mehta; Balarama Kaimal; Kirsten Lyons; Robert J Dempsey; Raghu Vemuganti
Journal:  J Neurosci       Date:  2016-06-29       Impact factor: 6.167

Review 5.  Strengths and limitations of genetic mouse models of Parkinson's disease.

Authors:  Marie-Francoise Chesselet; Sheila Fleming; Farzad Mortazavi; Bernd Meurers
Journal:  Parkinsonism Relat Disord       Date:  2008-06-27       Impact factor: 4.891

6.  Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease.

Authors:  Yong-Hwan Kim; Anand Rane; Stephanie Lussier; Julie K Andersen
Journal:  J Neurosci Res       Date:  2011-06-24       Impact factor: 4.164

7.  Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.

Authors:  Laura M Grant; Franziska Richter; Julie E Miller; Stephanie A White; Cynthia M Fox; Chunni Zhu; Marie-Francoise Chesselet; Michelle R Ciucci
Journal:  Behav Neurosci       Date:  2014-04       Impact factor: 1.912

Review 8.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

9.  Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.

Authors:  Vivian P Chou; Novie Ko; Theodore R Holman; Amy B Manning-Boğ
Journal:  J Vis Exp       Date:  2014-01-07       Impact factor: 1.355

Review 10.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.